On the latest episode of "AI in Life Sciences," we engage with the impressive multimodal, AI-driven technology patented by Openstream.ai. This technology promises to revolutionize operational efficiency across multiple sectors with its advanced capabilities. Also, we discuss a breakthrough in the biopharma industry - an AI platform capable of identifying promising early-stage assets and firms. We also delve into the pressing need for the integration of AI technology in the healthcare sector for improved patient care and operational efficiency. We round up the episode examining the implications of Novo's $1 billion deal in the field of cardiovascular medicine, a move that could redefine the cardiac treatment landscape. Tune in for these exciting insights and more.